You are using an older browser version. Please use a supported version for the best MSN experience.

4 Biotechs With Buyout Potential

The Pfizer-BioPharma deal has fueled buyout speculation leading to rally in share price of several biotechs. Here are four potential targets for large pharma companies, who are looking to bolster their cancer or gene therapy pipeline.

UP NEXT

UP NEXT

Recent Videos

Featured Partners

image beaconimage beaconimage beacon